The Effects of Risperidone and Olanzapine on Thinking
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00108368|
Recruitment Status : Completed
First Posted : April 15, 2005
Last Update Posted : January 21, 2009
The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition.
Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia Psychotic Disorders||Drug: Risperidone Drug: Olanzapine||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Single Group Assignment|
|Official Title:||The Cognitive Effects of Risperidone and Olanzapine|
|Study Start Date :||October 2003|
|Estimated Study Completion Date :||March 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00108368
|United States, California|
|VA Greater Los Angeles Healthcare System|
|Los Angeles, California, United States, 90073|